03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Heart disease & stroke
Dr. David D'Alessio
Director of the Division of Endocrinology and Metabolism at Duke University School of Medicine
press citation on 1 topic since 28 Aug 2026 · last quoted 28 Aug 2026
02 Quoted on · 1 of 29 topics
Dr. David D'Alessio: key facts
- Kind of voice
- Academic
- Role
- Director of the Division of Endocrinology and Metabolism at Duke University School of Medicine
- Quoted on
- Heart disease & stroke
- Tracked press citations
- 1
- Most recently quoted
- 28 Aug 2026
04 On the record · press
What Dr. David D'Alessio has said
- independent.co.uk1
Where Dr. David D'Alessio has been quoted
- 01Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risksindependent.co.uk · 28 Aug 2026
Verbatim
“Heart health deserves attention throughout the course of treatment, not just after a serious cardiovascular event. This approval gives patients a medicine that reduces the risk of cardiovascular events and supports metabolic health at the same time.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.